MedPath

Methyl aminolevulinate

Generic Name
Methyl aminolevulinate
Brand Names
Metvix, Metvixia
Drug Type
Small Molecule
Chemical Formula
C6H11NO3
CAS Number
33320-16-0
Unique Ingredient Identifier
585NM85KYM

Overview

Methyl aminolevulinate is a prodrug that is metabolised to Protoporphyrin IX (a photosensitizer) used in photodynamic therapy.

Indication

For topical use, in combination with 570 to 670 nm wavelength red light illumination, in the treatment of non-hyperkeratotic actinic keratoses of the face and scalp in immunocompetent patients when used in conjunction with lesion preparation (debridement using a sharp dermal curette).

Associated Conditions

  • Actinic Keratosis of Face and Scalp

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2023/02/13
N/A
Completed
2022/07/13
Not Applicable
Active, not recruiting
2021/11/02
Phase 2
Recruiting
Institut de Cancérologie de Lorraine
2017/01/06
Not Applicable
UNKNOWN
2015/07/29
Phase 1
Completed
2015/06/08
Phase 4
Completed
Joint Authority for Päijät-Häme Social and Health Care
2015/03/19
Not Applicable
Completed
Centre Hospitalier Universitaire de Nīmes
2015/02/27
Phase 3
Completed
University Hospital, Limoges
2011/11/21
Phase 3
Completed
2008/03/06
Phase 3
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
METVIX methyl aminolevulinate 160mg/g cream tube
93838
Medicine
A
4/4/2003
LUMEXIA methyl aminolevulinate 160 mg/g cream tube
231012
Medicine
A
6/1/2015

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.